| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4111211
Max Phase: Preclinical
Molecular Formula: C20H29NO
Molecular Weight: 299.46
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: C[C@]12C[C@H]3CC[C@@H]4C[C@@H](O)CC[C@H]4[C@@H]3C[C@@H]1CC/C2=C/C#N
Standard InChI: InChI=1S/C20H29NO/c1-20-12-14-3-2-13-10-17(22)6-7-18(13)19(14)11-16(20)5-4-15(20)8-9-21/h8,13-14,16-19,22H,2-7,10-12H2,1H3/b15-8-/t13-,14-,16+,17+,18-,19-,20-/m1/s1
Standard InChI Key: YZJXWZHAHLUZLG-FWWVCZNFSA-N
Associated Targets(non-human)
GABA receptor alpha-4 subunit 24 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 299.46 | Molecular Weight (Monoisotopic): 299.2249 | AlogP: 4.45 | #Rotatable Bonds: 0 |
| Polar Surface Area: 44.02 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 2 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: | CX LogP: 3.72 | CX LogD: 3.72 |
| Aromatic Rings: 0 | Heavy Atoms: 22 | QED Weighted: 0.67 | Np Likeness Score: 2.09 |
References
| 1. (2016) Neuroactive substituted cyclopenta[b]phenanthrenes as modulators for GABA type-A receptors, |
Source
Source(1):